Author:
Greenberg D C,Wright K A,Lophathanon A,Muir K R,Gnanapragasam V J
Publisher
Springer Science and Business Media LLC
Reference20 articles.
1. Adolfsson J, Garmo H, Varenhorst E, Ahlgren G, Ahlstrand C, Andrén O, Bill-Axelson A, Bratt O, Damber JE, Hellström K, Hellström M, Holmberg E, Holmberg L, Hugosson J, Johansson JE, Petterson B, Törnblom M, Widmark A, Stattin P (2007) Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005. Scand J Urol Nephrol 41 (6): 456–477.
2. Brewster DH, Fraser LA, Harris V, Black RJ (2000) Rising incidence of prostate cancer in Scotland: increased risk or increased detection? BJU Int 85 (4): 463–472.
3. Department of Health. The NHS cancer plan. London: Department of Health (2000) Department of Health, ‘Delivering the Cancer Reform Strategy. Report by the Controller and Auditor General,’ Tech. rep., HC 568., Session 2010–2011. Available at
http://www.nao.org.uk/wp-content/uploads/2010/11/1011568.pdf
.
4. Derweesh IH, Kupelian PA, Zippe C, Levin HS, Brainard J, Magi-Galluzzi C, Myles J, Reuther AM, Klein EA (2004) Continuing trends in pathological stage migration in radical prostatectomy specimens. Urol Oncol 22 (4): 300–306.
5. Dong F, Wang C, Farris AB, Wu S, Lee H, Olumi AF, McDougal WS, Young RH, Wu CL (2012) Impact on the clinical outcome of prostate cancer by the 2005 international society of urological pathology modified Gleason grading system. Am J Surg Pathol 36 (6): 838–843.
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献